Hypoxia, Latency and Reactivation in M tuberculosis
Hypoxia, Latency and Reactivation in M tuberculosis
批准号:
6346504
负责人:
DAVID R SHERMAN
金额:
$32.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2002-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by the applicant): Central to the pathogenic success of
Mycobacterium tuberculosis (MTB) is its ability to persist within humans for
long periods in a latent state, without causing any overt disease symptoms.
Roughly one-third of the world population harbors latent MTB, greatly
complicating efforts at tuberculosis control. A person with latent tuberculosis
has about a 10 percent lifetime chance of developing active disease, and when
such a person contracts HIV, the risk of developing reactivation TB increases
to 8 - 10 percent per year. Hypoxic conditions within the human host are widely
regarded as crucial for development of latent tuberculosis, but the MTB
adaptive response to hypoxia is at present very poorly understood. The goal of
this proposal is to define the MTB hypoxic response as it relates to latency
and reactivation. The a-crystallin protein of MTB is powerfully induced by
hypoxia and has been implicated in long-term survival. Alpha-crystallin will be
used as a model system to determine the mechanisms by which oxygen tension
control MTB gene expression. In addition, specific conditions in which
Alpha-crystallin is necessary for achieving latency and reactivation will be
determined. Finally, with Alpha-crystallin as an example, other proteins
important for the adaptation to and from hypoxia will be identified and
characterized. The result will be better tools to confront the threat to more
than one billion persons with latent tuberculosis, millions of whom are now or
will soon be co-infected with the human immunodeficiency virus, HIV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10665037
-
项目类别:
-
资助金额:$13.32万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10117593
-
项目类别:
-
资助金额:$73.08万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10493290
-
项目类别:
-
资助金额:$14.37万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10669196
-
项目类别:
-
资助金额:$72.12万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
A multifactorial pipeline to dissect combinatorial drug efficacy in Tuberculosis
-
批准号:10465068
-
项目类别:
-
资助金额:$70.51万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10271651
-
项目类别:
-
资助金额:$56.87万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Drug tolerance, bacterial heterogeneity and adverse TB treatment outcomes
-
批准号:10907961
-
项目类别:
-
资助金额:$33.99万
-
财政年份:2021
-
负责人:DAVID R SHERMAN
-
依托单位:
Project 2: Response to Treatment
-
批准号:10339374
-
项目类别:
-
资助金额:$74.61万
-
财政年份:2018
-
负责人:DAVID R SHERMAN
-
依托单位:
Parallel Microscopic Determination of Fitness (PMDF) to Assess Growth and Viability of Mycobacterium tuberculosis
-
批准号:9089849
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2015
-
负责人:DAVID R SHERMAN
-
依托单位:
Bacterial Determinants of TB Progression
-
批准号:8577274
-
项目类别:
-
资助金额:$58.47万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
Data Management and Resource Dissemination Core
-
批准号:8577291
-
项目类别:
-
资助金额:$17.88万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
2013 Tuberculosis Drug Development GRC
-
批准号:8520841
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2013
-
负责人:DAVID R SHERMAN
-
依托单位:
2011 Gordon Research Conference on Tuberculosis Drug Development
-
批准号:8125495
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2011
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7844978
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
A Novel Clock to Monitor M. tuberculosis in vivo
-
批准号:7574365
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2009
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:7016314
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6655602
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6857094
-
项目类别:
-
资助金额:$33.68万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6725521
-
项目类别:
-
资助金额:$35.1万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
Hypoxia, Latency and Reactivation in M.tuberculosis
-
批准号:6450621
-
项目类别:
-
资助金额:$16.66万
-
财政年份:2002
-
负责人:DAVID R SHERMAN
-
依托单位:
海外基金